Fieldpoint Private Securities’s GSK GSK Stock Holding History

Fieldpoint Private Securities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$21K	Sell	380 -4,334	-92%	-$239K	0.01%	611
2022 Q1	$257K	Sell	4,714 -136	-3%	-$7.39K	0.05%	280
2021 Q4	$267K	Buy	4,850 +3,531	+268%	+$184K	0.05%	287
2021 Q3	$63K	Sell	1,319 -224	-15%	-$11.3K	0.01%	520
2021 Q2	$78K	Buy	1,543 +145	+10%	+$6.97K	0.02%	476
2021 Q1	$62K	Buy	1,398 +662	+90%	+$30K	0.01%	519
2020 Q4	$34K	Buy	+736	New	+$33.8K	0.01%	553
2020 Q1	–	Sell	-233	Closed	-$14K	–	371
2019 Q4	$14K	Hold	233	–	–	﹤0.01%	553
2019 Q3	$12K	Hold	233	–	–	﹤0.01%	562
2019 Q2	$12K	Buy	+233	New	+$11.7K	﹤0.01%	600
2018 Q1	–	Sell	-80	Closed	-$4K	–	413
2017 Q4	$4K	Buy	+80	New	+$3.7K	﹤0.01%	367

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fieldpoint Private Securities's GSK Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its GSK (GSK) stake by 92% in Q2 2022, selling an estimated $239K and leaving 380 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #611.

Fieldpoint Private Securities first reported a position in GSK in Q4 2017 and has held it in 11 quarters since. The position peaked at $267K in Q4 2021. 901 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Fieldpoint Private Securities held 380 shares of GSK worth $21K as of Q2 2022.
Fieldpoint Private Securities sold 4,334 GSK shares in Q2 2022, an estimated $239K.
GSK made up 0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #611 holding.
Fieldpoint Private Securities first reported a position in GSK in Q4 2017 and has held it in 11 quarters since.
Fieldpoint Private Securities's GSK position peaked at $267K in Q4 2021.
901 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.